Skip to main content

Advertisement

SpringerLink
Log in

Transient Myeloproliferative Disorder and GATA1 Mutation in Neonates With and Without Down Syndrome

  • Original Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Objective

To report clinical experiences and cytogenetic findings of transient myeloproliferative disorder (TMD) in neonates with and without Down syndrome (DS).

Methods

GATA1 gene was screened in DNA samples from neonates presenting with TMD during their leukemic and remission status.

Results

Six neonates (2 phenotypically normal and 4 DS) born in the past 6 years had presented with TMD; all had trisomy 21 during leukemic status. Two DS infants died during early infancy, one of hepatic failure and one of cardiac complication. One non-DS infant evolved into myelodysplastic syndrome (MDS) and acute leukemia since 14 months old. Three other patients have not developed true leukemia after follow-up of 8, 9, and 70 months, respectively. The authors detected mutations within exon 2 of GATA1 gene in 3 DS and 2 non-DS infants. All these mutations disappeared after remission of TMD, but an identical mutation was detected in one non-DS patient when evolving into MDS. Trisomy 21 was confined to leukemic clone in non-DS patients.

Conclusions

TMD should be considered in case of congenital leukemia with megakaryoblastic features and accompanied by trisomy 21 and GATA1 mutation. Both DS and non-DS patients will possibly develop true leukemia within few years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Massey GV. Transient leukemia in newborns with Down syndrome. Pediatr Blood Cancer. 2005;44:29–32.

    Article  PubMed  Google Scholar 

  2. Schunk GJ, Lehman WL. Mongolism and congenital leukemia. JAMA. 1954;155:250–1.

    CAS  Google Scholar 

  3. Engel R, Hammond D. Transient congenital leukemia in 7 infants with mongolism. J Pediatr. 1964;65:303–5.

    Article  PubMed  CAS  Google Scholar 

  4. Magalhães IQ, Splendore A, Emerenciano M, et al. Transient neonatal myeloproliferative disorder without Down syndrome and detection of GATA1 mutation. J Pediatr Hematol Oncol. 2005;27:50–2.

    Article  PubMed  Google Scholar 

  5. Cushing T, Clericuzio CL, Wilson CS, et al. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder. J Pediatr. 2006;148:687–9.

    Article  PubMed  Google Scholar 

  6. Brissette MD, Duval-Arnould BJ, Gordon BG, Cotelingam JD. Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without Down syndrome. Am J Hematol. 1994;47:316–9.

    Article  PubMed  CAS  Google Scholar 

  7. Richards M, Welch J, Watmore A, Readett D, Vora AJ. Trisomy 21 associated transient neonatal myeloproliferation in the absence of Down’s syndrome. Arch Dis Child Fetal Neonatal Ed. 1998;79:F215–217.

    Article  PubMed  CAS  Google Scholar 

  8. Crispino JD. GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia. Pediatr Blood Cancer. 2005;44:40–4.

    Article  PubMed  Google Scholar 

  9. Gassas A, Doyle JJ, Weitzman S, et al. A basic classification and a comprehensive pediatric myeloproliferative disorder. J Pediatr Hematol Oncol. 2005;27:192–6.

    Article  PubMed  Google Scholar 

  10. Massey GV, Zipursky A, Chang MN, et al. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): a Children’s Oncology Group (COG) study POG-9481. Blood. 2006;107:4606–13.

    Article  PubMed  CAS  Google Scholar 

  11. Vyas P, Crispino JD. Molecular insights into Down syndrome-associated leukemia. Curr Opin Pediatr. 2007;19:9–14.

    Article  PubMed  Google Scholar 

  12. Greene ME, Mundschau G, Wechsler J, et al. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome. Blood Cells Mol Dis. 2003;31:351–6.

    Article  PubMed  CAS  Google Scholar 

  13. Ahmed M, Sternberg A, Hall G, et al. Natural history of GATA1 mutations in Down syndrome. Blood. 2004;103:2480–9.

    Article  PubMed  CAS  Google Scholar 

  14. Zipursky A, Brown EJ, Christensen H, Doyle J. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome. Clin Lab Med. 1999;19:157–67.

    PubMed  CAS  Google Scholar 

  15. Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukemia and solid tumors in individuals with Down’s syndrome. Lancet. 2000;355:165–9.

    Article  PubMed  CAS  Google Scholar 

  16. Massey GV. Transient leukemia in newborns with Down syndrome. Pediatr Blood Cancer. 2005;44:29–32.

    Article  PubMed  Google Scholar 

  17. Brink DS. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome. Adv Anat Pathol. 2006;13:256–62.

    Article  PubMed  Google Scholar 

  18. Zipursky A, Brown E, Christensen H, Sutherland R, Doyle J. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome. Semin Perinatol. 1997;21:97–101.

    Article  PubMed  CAS  Google Scholar 

  19. Adam M, Vincenot A, Gouraud F, et al. Transient myeloproliferative disorder in a neonate without Down syndrome. Ann Biol Clin (Paris). 2007;65:569–73.

    CAS  Google Scholar 

  20. Wechsler J, Greene M, McDevitt MA, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet. 2002;32:148–52.

    Article  PubMed  CAS  Google Scholar 

  21. Li Z, Godinho FJ, Klusmann JH, Garriga-Canut M, Yu C, Orkin SH. Developmental stage selective effect of somatically mutated leukemogenic transcription factor GATA1. Nat Genet. 2005;37:613–9.

    Article  PubMed  CAS  Google Scholar 

  22. Muntean AG, Crispino JD. Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development. Blood. 2005;106:1223–31.

    Article  PubMed  CAS  Google Scholar 

  23. Carpenter E, Valverde-Garduno V, Sternberg A, Mitchell C, Roberts I, Vyas R. GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder. Br J Haematol. 2005;128:548–51.

    Article  PubMed  CAS  Google Scholar 

  24. Gurbuxani S, Vyas P, Crispino JD. Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. Blood. 2004;103:399–406.

    Article  PubMed  CAS  Google Scholar 

  25. Xu G, Kato K, Toki T, Yoshihiro T, Kiminori T, Ito E. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder. J Pediatr Hematol Oncol. 2006;28:696–8.

    Article  PubMed  CAS  Google Scholar 

  26. Chou ST, Opalinska JB, Yao Y, et al. Trisomy 21 enhances human fetal erythro-megakaryocytic development. Blood. 2008;112:4503–6.

    Article  PubMed  CAS  Google Scholar 

  27. Stark B, Jeison M, Preudhomme C, et al. Acquired trisomy 21 and distinct clonal evolution in acute megakaryoblastic leukaemia in young monozygotic twins. Br J Haematol. 2002;118:1082–6.

    Article  PubMed  CAS  Google Scholar 

  28. Rainis L, Bercovich D, Strehl S, et al. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood. 2003;102:981–6.

    Article  PubMed  CAS  Google Scholar 

  29. Pine SR, Guo Q, Yin C, Jayabose S, Druschel CM, Sandoval C. Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. Blood. 2007;110:2128–31.

    Article  PubMed  CAS  Google Scholar 

  30. Shin MG, Choi HW, Kim HR, et al. Tetrasomy 21 as a sole acquired abnormality without GATA1 gene mutation in pediatric acute megakaryoblastic leukemia: a case report and review of the literature. Leuk Res. 2008;32:1615–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Contributions MHT; design and write this article, CPY; the corresponding author, JWH; responsible for all cytogenetic and all other five co-authors were major physicians of these patients during neonatal periods.

Conflict of Interest

None.

Role of Funding Source

None.

Author information

Authors and Affiliations

  1. Division of Pediatric Hematology/Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, 5, Fu-Shing St, Kwei-Shan, Taoyuan, 333, Taiwan

    Ming-Horng Tsai & Chao-Ping Yang

  2. Division of Pediatric Neonatology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan

    Pong-Hong Yang, Shih-Ming Chu, Jen-Fu Hsu, Ming-Chou Chiang & Hsuan-Rong Huang

  3. Division of Medical Genetics, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan

    Jia-Woei Hou

  4. Division of Neonatology and Pediatric Hematology/Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, Yunlin, Taiwan

    Ming-Horng Tsai

  5. Chang Gung University School of Medicine, Taoyuan, Taiwan

    Ming-Horng Tsai, Jia-Woei Hou, Chao-Ping Yang, Pong-Hong Yang, Shih-Ming Chu, Jen-Fu Hsu, Ming-Chou Chiang & Hsuan-Rong Huang

Authors
  1. Ming-Horng Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jia-Woei Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chao-Ping Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pong-Hong Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shih-Ming Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jen-Fu Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ming-Chou Chiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hsuan-Rong Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chao-Ping Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsai, MH., Hou, JW., Yang, CP. et al. Transient Myeloproliferative Disorder and GATA1 Mutation in Neonates With and Without Down Syndrome. Indian J Pediatr 78, 826–832 (2011). https://doi.org/10.1007/s12098-010-0312-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-010-0312-x

Keywords

Search

Navigation